Skip to main content
fbc logo
  • facebook-social
  • linkedin-social
  • Home
  • About
  • Practices
  • Practices
      • Arbitration & Mediation
      • Aviation & Maritime
      • Banking & Finance
      • Blockchain and Cryptocurrency
      • Capital Markets
      • Class Actions & Derivative Suits
      • Commercial
      • Competition & Antitrust
      • Cybersecurity, IT & Data Protection
      • East Asia Desk
      • Environmental
      • Family & Inheritance Law
      • Financial Regulation
      • FinTech
      • French Desk
      • Global Talent Mobility & Relocation
      • Hi-Tech, Technology & Venture Capital
      • Hotels & Tourism
      • Insolvency & Restructuring
      • Intellectual Property
      • Investment Funds
      • Labor & Employment
      • Life Sciences & Healthcare
      • Liquidation & Receivership
      • Litigation
      • Mergers & Acquisitions
      • Philanthropy
      • Planning & Zoning
      • Private Asset Management
      • Private Equity
      • Project Finance & Energy
      • Real Estate
      • Regulatory
      • Sports Law
      • Tax
      • Tax - Municipal Tax
      • Tech Litigation
      • Telecom & Media
      • Trade Associations
      • White Collar
  • Team
  • News
  • Community
  • Alumni
  • Careers
  • Contact
  • FBC Online
  • Accessibility
  • Subscribe

Representation of Bristol-Myers Squibb Company in its $12M Investment in Compugen Ltd.

By Raz Tepper & Sharon Rosen | Oct 2018 | Transaction

FBC represented Bristol-Myers Squibb Company (NYSE: BMY) in connection with its $12M equity investment in Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery.
The equity offering was made as a private placement of public equity (PIPE). The equity investment is being made in conjunction with a clinical trial collaboration entered into between Bristol-Myers Squibb’s and Compugen to evaluate the safety and tolerability of Compugen’s COM701, an investigational anti-PVRIG antibody, in combination with Bristol-Myers Squibb’s programmed death-1 (PD-1) immune checkpoint inhibitor Opdivo (nivolumab), in patients with advanced solid tumors.
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

For press coverage, see here and here.

Search by

General Search

Practice Area

  • Arbitration & Mediation
  • Aviation & Maritime
  • Banking & Finance
  • Blockchain and Cryptocurrency
  • Capital Markets
  • Class Actions & Derivative Suits
  • Commercial
  • Competition & Antitrust
  • Cybersecurity, IT & Data Protection
  • East Asia Desk
  • Environmental
  • Family & Inheritance Law
  • Financial Regulation
  • FinTech
  • French Desk
  • Global Talent Mobility & Relocation
  • Hi-Tech, Technology & Venture Capital
  • Hotels & Tourism
  • Insolvency & Restructuring
  • Intellectual Property
  • Investment Funds
  • Labor & Employment
  • Life Sciences & Healthcare
  • Liquidation & Receivership
  • Litigation
  • Mergers & Acquisitions
  • Philanthropy
  • Planning & Zoning
  • Private Asset Management
  • Private Equity
  • Project Finance & Energy
  • Real Estate
  • Regulatory
  • Sports Law
  • Tax
  • Tax - Municipal Tax
  • Tech Litigation
  • Telecom & Media
  • Trade Associations
  • White Collar

Attorney

Date

  • Last Month
  • Last Six Months
  • Last Year

Publication Type

  • Transaction
  • Publication
  • Legal Update
  • Firm News
Clear Search
Israel Law Firm of the year by IFLR 1000 for 2020

Recent News & Publications

מעו”דכן תכנון ובניה – יולי 2025

ביום 1.7.2025 פורסמו תקנות התכנון והבניה (רישוי בניה) (הוראת שעה) (מס' 2), התשפ"ה - 2025, הקובעות כי בתקופה של 120 ימים מיום פרסום התקנות, ר...

Yaniv Gorelik | Jul 2025

מעו”דכן מחלקת לקוחות פרטיים, ניהול הון משפחתי והעברות בין-דוריות בעסקים משפחתיים – חידושים בצוואות הדדיות – יולי 2025

בעדכון לקוחות זה נסקור בפניכם סוגיה אשר התעוררה לאחרונה באופן תדיר הן בפסיקת בית המשפט העליון, הן בפסיקת בית המשפט המחוזי, הן במאמציי המחוקק...

Shalom Hershkovitz & Sagi Katz & Eldad Meller & Shahar Lifshitz, Prof. | Jul 2025

IBA Healthcare and Life Sciences Law Committee survey on healthcare financing and reimbursement 2025

We are pleased to share with you the 2025 legal guide on healthcare financing and reimbursement, compiled by the IBA Healthcare and Life Sci...

Sharon Gazit & Judy Amidor & Lennie Zivoni & Alexander Vatrunin | Jul 2025
View all News >>
Practice Areas
    • Arbitration & Mediation
    • Aviation & Maritime
    • Banking & Finance
    • Blockchain and Cryptocurrency
    • Capital Markets
    • Class Actions & Derivative Suits
    • Commercial
    • Competition & Antitrust
    • Cybersecurity, IT & Data Protection
    • East Asia Desk
    • Environmental
    • Family & Inheritance Law
    • Financial Regulation
    • FinTech
    • French Desk
    • Global Talent Mobility & Relocation
    • Hi-Tech, Technology & Venture Capital
    • Hotels & Tourism
    • Insolvency & Restructuring
    • Intellectual Property
    • Investment Funds
    • Labor & Employment
    • Life Sciences & Healthcare
    • Liquidation & Receivership
    • Litigation
    • Mergers & Acquisitions
    • Philanthropy
    • Planning & Zoning
    • Private Asset Management
    • Private Equity
    • Project Finance & Energy
    • Real Estate
    • Regulatory
    • Sports Law
    • Tax
    • Tax - Municipal Tax
    • Tech Litigation
    • Telecom & Media
    • Trade Associations
    • White Collar
Attorneys by Practice
    • Arbitration & Mediation
    • Aviation & Maritime
    • Banking & Finance
    • Blockchain and Cryptocurrency
    • Capital Markets
    • Class Actions & Derivative Suits
    • Commercial
    • Competition & Antitrust
    • Cybersecurity, IT & Data Protection
    • East Asia Desk
    • Environmental
    • Family & Inheritance Law
    • Financial Regulation
    • FinTech
    • French Desk
    • Global Talent Mobility & Relocation
    • Hi-Tech, Technology & Venture Capital
    • Hotels & Tourism
    • Insolvency & Restructuring
    • Intellectual Property
    • Investment Funds
    • Labor & Employment
    • Life Sciences & Healthcare
    • Liquidation & Receivership
    • Litigation
    • Mergers & Acquisitions
    • Philanthropy
    • Planning & Zoning
    • Private Asset Management
    • Private Equity
    • Project Finance & Energy
    • Real Estate
    • Regulatory
    • Sports Law
    • Tax
    • Tax - Municipal Tax
    • Tech Litigation
    • Telecom & Media
    • Trade Associations
    • White Collar
Team Member by Name
All Rights Reserved, FBC&Co
Photography by Ofir Abe | Designed By Hastudeö | Developed By Beaverglobal